Study of 72-Hour Infusion of ON 01910.Na in Patients With MDS or AML
NCT00854945
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Myelodysplastic Syndrome
Acute Myeloid Leukemia
Interventions
DRUG:
ON 01910.Na
Sponsor
Traws Pharma, Inc.